The Oncology Institute, Inc. TOI Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s shares (diluted)?
- The Oncology Institute, Inc. (TOI) reported shares (diluted) of 101.8M in Q1 2026.
- How has The Oncology Institute, Inc.'s shares (diluted) changed year-over-year?
- The Oncology Institute, Inc.'s shares (diluted) increased by 32.0% year-over-year, from 77.1M to 101.8M.
- What is the long-term trend for The Oncology Institute, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s shares (diluted) has grown at a 8.4% compound annual growth rate (CAGR), from 261.1M to 360.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.